Chardan Capital Maintains Buy on Oculis Holding, Maintains $28 Price Target

Benzinga · 01/07 13:13
Chardan Capital analyst Daniil Gataulin maintains Oculis Holding (NASDAQ:OCS) with a Buy and maintains $28 price target.